FDA Investigator Katlin N Stubbs

Katlin N Stubbs has conducted inspections on 33 sites in 3 countries as of 01 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
33
Last Inspection Date:
01 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
100002137
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Spain
FDA Investigators that have inspected at least one site in common with Katlin N Stubbs:
Adam S Freeman, Akbar J Zaidi, Alexandria L Capuano, Alla Dubrovsky, Althea A Williams, Armando Chavez, MS, Axel M Ambert, Brenda G Stewart Munoz, Brittny C Cargo, Charles D Brown, Charles L Larson, Cheryl D Mccall, Christine I Shaw, Cindy W Lewis, Creighton T Tuzon, Cynthia A Harris, MD, RN, David M Beltran, Deatherage Kayla, Denise Connelly, Dennis R Hock, Edward E Lockwood (EEL), Elizabeth A Dakan, Elizabeth D Connell, Ellen J Tave, Eric W Anderson, Gladys B Casper, Iris C Macinnes, J Elkins, Jacey Roy, James R Montero, Janet B Abt, Janet Pulver, Janete F Guardia, Jd Young, Jeffrey R Wooley, Jennifer A Robinson, Jennifer Cunningham, Jeremy L Stukes, Joan T Briones, Jocelyn C Turner, Jocelyn T Ramos, Jonathan A Womack, Juan A Morales, Julian C Hanson, Katelyn Astaub Zamperini, Kayla R Deatherage, Keren Arkin, Lance D Johnson, Lauren E Skokan, Leighton Kn Gai, Linda Linh N Adams, Lydia S Chan, Maida Henesian (NMI), Marie K Kinkade, Mark E Chan, Marlo Ianm Alintanahin, Michelle A Krayer, Michelle J Glembin, Patty P Kaewussdangkul, Paul R Whitby, Pauline N Logan, Quynh H Strandberg, Richard T Riggie, Robert E Spear, Ronda Rloyd Jones, Rose Ashley, Roy Baby, Sergio Chavez (NMI), Sherri N Rohlf, MD, Sherrie L Krolczyk, Terren L Cheesbro, Thea C Grome, Timothy B Webb, Timothy H Vo, Trina K Vick, Vitaliy N Guyvan

Katlin N Stubbs's Documents

Publish Date Document Type Title
December, 2023 FDA 483 ErgoMed, Inc. - Form 483, 2023-12-06
October, 2023 FDA 483 Post Oak Innovations, Inc. - Form 483, 2023-10-13
October, 2022 FDA 483 GRAMERCY EXTREMITY ORTHOPEDICS - Form 483, 2022-10-06
June, 2023 FDA 483 Wello, Inc. - Form 483, 2023-06-21
January, 2024 FDA 483 Bound Tree Medical, LLC - Form 483, 2024-01-31
November, 2023 FDA 483 AEI Technologies, Inc - Form 483, 2023-11-16
March, 2023 FDA 483 Micro Distributing I I, Ltd - Form 483, 2023-03-07
August, 2023 FDA 483 Cardionics, Inc - Form 483, 2023-08-30
March, 2024 FDA 483 Argon Medical Devices, Inc - Form 483, 2024-03-19
January, 2023 FDA 483 Midwest Sterilization Corporation - Form 483, 2023-01-12
May, 2023 FDA 483 Morgan Newton Comp. - Form 483, 2023-05-12
January, 2024 FDA 483 Dalton Medical Corp - Form 483, 2024-01-22
January, 2023 FDA 483 MPM Medical LLC - Form 483, 2023-01-05
October, 2022 FDA 483 iMed Technology, Inc - Form 483, 2022-10-18
July, 2023 FDA 483 Inmar Supply Chain Solutions, LLC - Form 483, 2023-07-19
September, 2023 FDA 483 Quicksilver Scientific - Form 483, 2023-09-21
April, 2022 FDA 483 Abbott Diabetes Care, Inc. - Form 483, 2022-04-21
July, 2024 FDA 483 iRhythm Technologies, Inc. - Form 483, 2024-07-31
July, 2024 FDA 483 NEUROLOGICAL FITNESS EQUIPMENT and EDUCATION LLC, dba NEUFIT - Form 483, 2024-07-03
September, 2024 FDA 483 Rockwell Medical, Inc. - Form 483, 2024-09-16
October, 2024 FDA 483 Brius Technologies Inc. - Form 483, 2024-10-07
August, 2023 EIR Sterigenics U.S., LLC - EIR, 2023-08-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more